Company profile for Sinovac Biotech

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. Sinovac's product portfolio includes vaccines against enterovirus71 (EV71), hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), varicella vaccine and mumps. Healive, the hepat...
Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. Sinovac's product portfolio includes vaccines against enterovirus71 (EV71), hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), varicella vaccine and mumps. Healive, the hepatitis A vaccine manufactured by the Company, has passed the assessment under WHO prequalification procedures in 2017.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
No.39, SHANGDI West Road, Haidian District, Beijing, P.R.C.
Telephone
Telephone
+86-10-8289-0088
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

PEGS Boston Summit

PEGS Boston Summit

Not Confirmed

envelop Contact Supplier

PEGS Boston Summit

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20260520175565/en/SINOVAC-Announces-Extension-of-Deadline-to-Submit-Payment-Instructions-for-Previously-Declared-Special-Cash-Dividend

BUSINESSWIRE
21 May 2026

https://firstwordpharma.com/story/7416244

FIRSTWORD PHARMA
09 May 2026

https://www.businesswire.com/news/home/20260429934070/en/SINOVAC-Files-Annual-Report-on-Form-20-F-for-the-Fiscal-Year-2024

BUSINESSWIRE
30 Apr 2026

https://www.businesswire.com/news/home/20260122376718/en/SINOVAC-Announces-Nasdaq-Hearings-Panel-Grants-Continued-Listing

BUSINESSWIRE
22 Jan 2026

https://www.businesswire.com/news/home/20260104600593/en/Sinovac-Receives-Nasdaq-Notification-Regarding-Late-Filing-of-2025-Half-Year-Report

BUSINESSWIRE
04 Jan 2026

https://www.businesswire.com/news/home/20260104122574/en/SINOVAC-Provides-Update-on-Antigua-High-Court-Order-and-Auditor-Engagement

BUSINESSWIRE
04 Jan 2026

ABOUT THIS PAGE

Contact Sinovac Biotech and get a quotation

Sinovac Biotech is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find Captopril bulk offered by Sinovac Biotech

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty